CG Oncology (CGON)
Developing cretostimogene for bladder cancer alongside contract fill-and-finish manufacturing.
$77.74
After hours0.00 (0.00%)
At close$77.74(−0.65%)
Something off on this page? Send us feedback.
Next report
Nov 13, 26
estimated · in 52 days
EPS estimate
−$0.86
Revenue estimate
$547.7K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.48−$0.45−$0.54−$0.57−$0.51−$0.71−$0.90Pending
Estimate−$0.41−$0.39−$0.49−$0.56−$0.61−$0.58−$0.66−$0.86
Surprise−17.1%−15.4%−10.2%−2.0%+16.4%−22.4%−35.5%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$456.0K$52.0K—$1.7M$2.3M$1.1M$1.2MPending
Estimate$124.0K$118.2K$81.6K$59.4K$450.5K$453.0K$360.8K$547.7K
Surprise+267.9%−56.0%—+2,706.4%+412.9%+139.1%+220.7%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.71 | — | — |
| Sep 2027 | −$0.78 | — | — |
| Jun 2027 | −$0.86 | — | — |
| Mar 2027 | −$0.91 | — | — |
| Dec 2026 | −$0.85 | — | — |
| Nov 2026 | −$0.86 | — | — |
| Aug 2026 | −$0.66 | −$0.90 | −35.5% |
| May 2026 | −$0.58 | −$0.71 | −22.4% |
| Feb 2026 | −$0.61 | −$0.51 | +16.4% |
| Nov 2025 | −$0.56 | −$0.57 | −2.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | −$0.42 | — | — |
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | −$0.67 | — | — |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.71 | — | — | $23.7M | — | — | — |
| Sep 2027 | −$0.78 | — | — | $17.0M | — | — | — |
| Jun 2027 | −$0.86 | — | — | $11.3M | — | — | — |
| Mar 2027 | −$0.91 | — | — | $25.0M | — | — | — |
| Dec 2026 | −$0.85 | — | — | $522.9K | — | — | — |
| Nov 13, 2026 | −$0.86 | — | — | $547.7K | — | — | — |
| Aug 6, 2026 | −$0.66 | −$0.90 | −35.5% | $360.8K | $1.2M | +220.7% | +3.4% |
| May 8, 2026 | −$0.58 | −$0.71 | −22.4% | $453.0K | $1.1M | +139.1% | +0.6% |
| Feb 27, 2026 | −$0.61 | −$0.51 | +16.4% | $450.5K | $2.3M | +412.9% | +4.8% |
| Nov 14, 2025 | −$0.56 | −$0.57 | −2.0% | $59.4K | $1.7M | +2,706.4% | +8.6% |
| Aug 8, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 28, 2025 | |||||||
| Nov 14, 2024 | −$0.42 | — | — | $113.0K | — | — | — |
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 26, 2024 | −$0.67 | — | — | — | — | — | — |